Asrin Ahmadi

525 total citations
10 papers, 405 citations indexed

About

Asrin Ahmadi is a scholar working on Pharmacology, Hepatology and Oncology. According to data from OpenAlex, Asrin Ahmadi has authored 10 papers receiving a total of 405 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pharmacology, 5 papers in Hepatology and 4 papers in Oncology. Recurrent topics in Asrin Ahmadi's work include Liver Disease and Transplantation (5 papers), Drug-Induced Hepatotoxicity and Protection (5 papers) and Drug Transport and Resistance Mechanisms (4 papers). Asrin Ahmadi is often cited by papers focused on Liver Disease and Transplantation (5 papers), Drug-Induced Hepatotoxicity and Protection (5 papers) and Drug Transport and Resistance Mechanisms (4 papers). Asrin Ahmadi collaborates with scholars based in Iran, China and India. Asrin Ahmadi's co-authors include Reza Heidari, Hossein Niknahad, Negar Azarpira, Mohammad Mehdi Ommati, Hamidreza Mohammadi, Vahid Ghanbarinejad, Akram Jamshidzadeh, Narges Abdoli, Omid Farshad and Forouzan Khodaei and has published in prestigious journals such as SHILAP Revista de lepidopterología, Biomedicine & Pharmacotherapy and Toxicology Letters.

In The Last Decade

Asrin Ahmadi

10 papers receiving 401 citations

Peers

Asrin Ahmadi
Asrin Ahmadi
Citations per year, relative to Asrin Ahmadi Asrin Ahmadi (= 1×) peers Khadijeh Mousavi

Countries citing papers authored by Asrin Ahmadi

Since Specialization
Citations

This map shows the geographic impact of Asrin Ahmadi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Asrin Ahmadi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Asrin Ahmadi more than expected).

Fields of papers citing papers by Asrin Ahmadi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Asrin Ahmadi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Asrin Ahmadi. The network helps show where Asrin Ahmadi may publish in the future.

Co-authorship network of co-authors of Asrin Ahmadi

This figure shows the co-authorship network connecting the top 25 collaborators of Asrin Ahmadi. A scholar is included among the top collaborators of Asrin Ahmadi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Asrin Ahmadi. Asrin Ahmadi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Ahmadi, Asrin, Hossein Niknahad, Huifeng Li, et al.. (2021). The inhibition of NFкB signaling and inflammatory response as a strategy for blunting bile acid-induced hepatic and renal toxicity. Toxicology Letters. 349. 12–29. 41 indexed citations
2.
Mousavi, Khadijeh, Hossein Niknahad, Huifeng Li, et al.. (2021). The activation of nuclear factor-E2-related factor 2 (Nrf2)/heme oxygenase-1 (HO-1) signaling blunts cholestasis-induced liver and kidney injury. Toxicology Research. 10(4). 911–927. 29 indexed citations
3.
Heidari, Reza, Asrin Ahmadi, Mohammad Mehdi Ommati, & Hossein Niknahad. (2020). Methylene Blue Improves Mitochondrial Function in The Liver of Cholestatic Rats. SHILAP Revista de lepidopterología. 5 indexed citations
4.
Ghanbarinejad, Vahid, Asrin Ahmadi, Hossein Niknahad, Mohammad Mehdi Ommati, & Reza Heidari. (2019). Carnosine Mitigates Manganese Mitotoxicity in an In Vitro Model of Isolated Brain Mitochondria. Advanced Pharmaceutical Bulletin. 9(2). 294–301. 10 indexed citations
6.
Heidari, Reza, Hamidreza Mohammadi, Vahid Ghanbarinejad, et al.. (2018). Proline supplementation mitigates the early stage of liver injury in bile duct ligated rats. Journal of Basic and Clinical Physiology and Pharmacology. 30(1). 91–101. 33 indexed citations
7.
Heidari, Reza, Vahid Ghanbarinejad, Hamidreza Mohammadi, et al.. (2018). Dithiothreitol supplementation mitigates hepatic and renal injury in bile duct ligated mice: Potential application in the treatment of cholestasis-associated complications. Biomedicine & Pharmacotherapy. 99. 1022–1032. 39 indexed citations
8.
Heidari, Reza, Hossein Niknahad, Hamidreza Mohammadi, et al.. (2018). Betaine treatment protects liver through regulating mitochondrial function and counteracting oxidative stress in acute and chronic animal models of hepatic injury. Biomedicine & Pharmacotherapy. 103. 75–86. 91 indexed citations
9.
Heidari, Reza, Asrin Ahmadi, Hamidreza Mohammadi, et al.. (2018). Mitochondrial dysfunction and oxidative stress are involved in the mechanism of methotrexate-induced renal injury and electrolytes imbalance. Biomedicine & Pharmacotherapy. 107. 834–840. 93 indexed citations
10.
Heidari, Reza, Vahid Ghanbarinejad, Hamidreza Mohammadi, et al.. (2017). Mitochondria protection as a mechanism underlying the hepatoprotective effects of glycine in cholestatic mice. Biomedicine & Pharmacotherapy. 97. 1086–1095. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026